Location: Menlo Park, CA
CIK: 0002010850 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 14, 2024
Total Value: $746M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Alpine Immune Sciences, Inc. | 8,317,924 | $330M | 44.2% | $22.11 | — | COM | 02083G100 |
| CGON | CG ONCOLOGY INC | 5,458,810 | $240M | 32.1% | $40.84 | 0.0% | COM | 156944100 |
| ZNTL | Zentalis Pharmaceuticals Inc. | 2,099,583 | $33.09M | 4.4% | $14.59 | -5.7% | COM | 98943L107 |
| ILMN | Illumnia, Inc. | 129,067 | $17.72M | 2.4% | $122.34 | +9.6% | COM | 452327109 |
| BYSI | BeyondSpring Inc. | 4,958,143 | $17.7M | 2.4% | $0.92 | +83.3% | SHS | G10830100 |
| RCUS | Arcus Biosciences, Inc | 869,790 | $16.42M | 2.2% | $15.98 | +8.2% | COM | 03969F109 |
| KRYS | KRYSTAL BIOTECH INC | 65,772 | $11.7M | 1.6% | $110.89 | +25.3% | COM | 501147102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 347,835 | $11.08M | 1.5% | $25.51 | 0.0% | COM | 35104E100 |
| EQ | Equillium Inc. | 4,447,308 | $10.27M | 1.4% | $0.59 | +192.5% | COM | 29446K106 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 850,000 | $9.027M | 1.2% | $8.62 | -1.4% | COM | 71722W107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 166,600 | $8.368M | 1.1% | $50.23 | — | COM | G4444C102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 157,958 | $7.394M | 1.0% | $39.13 | 0.0% | COM | 22663K107 |
| — | 10x Genomics, Inc. | 195,835 | $7.35M | 1.0% | $55.96 | — | CL A COM | 88025u109 |
| CYTK | CYTOKINETICS INC | 94,043 | $6.593M | 0.9% | $77.34 | 0.0% | COM | 23282W605 |
| LEGN | LEGEND BIOTECH CORP-ADR | 86,363 | $4.844M | 0.6% | $56.09 | — | ADR | 52490G102 |
| — | MERUS NV | 101,798 | $4.584M | 0.6% | $45.03 | — | COM | N5749R100 |
| AURA | Aura Biosciences, Inc. | 515,555 | $4.047M | 0.5% | $8.47 | -2.1% | COM | 05153U107 |
| HLTHQ | Cue Health Inc. | 8,980,909 | $1.697M | 0.2% | $0.16 | — | COM | 229790100 |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | $1.392M | 0.2% | $1.71 | +145.6% | COM | 747324101 |
| WHWK | Aadi Bioscience, Inc. | 526,329 | $1.232M | 0.2% | $4.20 | -54.1% | COM | 00032Q104 |
| WGS | GeneDx Holdings Corp. | 103,604 | $946K | 0.1% | $2.33 | +158.2% | COM CL A | 81663L200 |
| ATRC | AtriCure Inc. | 26,797 | $815K | 0.1% | $37.19 | -9.9% | COM | 04963C209 |